XPHYF News and Press, XPhyto Therapeutics Corp From 01/28/21

Construction of commercial drug manufacturing facility in Germany Four clinical studies in neurological indications in 2021 Development of oral biosensor and contract development & manufacturing Psychedelic transdermal and sublingual drug formulation development VANC...

VANCOUVER, BC / ACCESSWIRE / January 22, 2021 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto " or the " Corporation ") at the request of OTC Markets, is providing the following comments regarding recent promotional activity with respect to the Corporation. ...

Commercialization of rapid COVID-19 PCR test Clinical validation of transdermal and sublingual drug formulations Psychedelic API production, drug formulation and clinical integration VANCOUVER, BC / ACCESSWIRE / January 18, 2021 / XPhyto Therapeutics Corp . ( CSE:XPHY / ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / January 15, 2021 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto " or the " Company "), has completed its previously announced...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / January 5, 2021 / XPhyto Therapeutics Corp . ( CSE:XPHY) (OTC:XPHYF) (FSE:4XT ) (" XPhyto " or the " Company "), is pleased to announce a non-brokered pri...

NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the December 17th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and inter...

VANCOUVER, BC / ACCESSWIRE / December 17, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY / OTCQB:XPHYF / FSE:4XT ) (" XPhyto " or the " Company "), a next-generation bioscience accelerator, and its exclusive German diagnostics development partner, 3a-diagnostics GmbH ("3a"), are pleased to ...

NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and ...

VANCOUVER, BC / ACCESSWIRE / December 11, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY / OTCQB:XPHYF / FSE:4XT ) (" XPhyto " or the " Company "), announces that the Company will present at the virtual LD Micro Main Event (XIII) taking place December 14-15, 2020. Hugh Rogers, CEO and Dire...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / December 8, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY) (OTC:XPHYF) (FSE:4XT ) (" XPhyto " or the " Company "), is pleased to announce that it has close...